 |
|
|
||
   |
Deep Life Sciences capital-raising expertise. For publicly traded life sciences companies, Brinson Patrick Securities Corporation has the proven expertise to raise the capital needed to grow a business. Driven by the vagaries of research, regulatory oversight, and the rigor and cost of clinical development, life sciences is arguably one of the most dynamic and complex of all industries, with multiple factors affecting capital requirements and funding needs. At-the-market offerings such as Brinson Patrick's DOCS® (Dynamic Offering of Common Stock) ATM financing facility enable life sciences companies ultimate flexibility to raise smaller amounts of cash, and to start and stop that flow as R&D or other initiatives demand. To learn more about our Life Sciences expertise, or how the DOCS® ATM offering can serve you, please contact us. » See how our DOCS® ATM enabled life sciences clients to meet their goals |
“Brinson Patrick offers a unique financing vehicle
that is well suited for a public life sciences company with liquidity in
their stock, with positive news flow, and with a need to consistently
raise money over time. There are so many creative ways a public life
sciences company can use the DOCS® facility from Brinson
Patrick.”  |